Zita

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zita

Quick Facts

Property Description
Active ingredients Acetaminophen and Caffeine
Form Oral solid form (Tablet or Capsule)
Pharmacological class Analgesic Combination and Antipyretic
Common use Systemic pain relief and fever regulation
Origin Synthetic chemical compounds

What Type of Medicine is Zita?

Zita is a medicinal entity defined as a fixed-dose combination product, containing two distinct active ingredients in a single oral solid form intended for the oral route of administration. It is classified in the high-level pharmacological class of an analgesic combination and antipyretic. Unlike single-entity pain relievers, this specific formulation is designed to deliver a synergistic effect through the simultaneous action of its two components. The combination of these agents is recognized in clinical practice as an effective strategy for managing common discomforts.


Zita Composition: Acetaminophen and Caffeine

The active composition of Zita consists of the two principal synthetic chemical compounds: Acetaminophen (Paracetamol) and Caffeine (1,3,7-trimethylxanthine). Acetaminophen serves as the primary component for pain relief and fever reduction, while Caffeine is included as an adjuvant—a supporting substance intended to enhance the therapeutic efficacy of the main drug. Caffeine acts as a Central Nervous System (CNS) stimulant which notably increases the effectiveness of common pain relievers.


General Purpose of the Combination

The general therapeutic purpose of the Acetaminophen-Caffeine combination is to provide effective systemic pain relief and facilitate fever regulation. This formulation is used to alleviate common forms of discomfort, such as mild aches and pains. The role of combination analgesics includes providing augmented efficacy against various pain types. The combination is specifically valued when a rapid onset of relief for acute pain, such as a tension headache, is desired. The adjuvant role of Caffeine is crucial, as it helps to potentiate the analgesic effect, meaning the combined effect on general discomfort is often greater than that achieved by Acetaminophen used alone.

Regulatory References

  1. NIH/MedlinePlus Drug Information on Acetaminophen
  2. Combination analgesics for acute pain (PMC article)

What side effects are possible with Zita?

Possible Side Effects and Safety Information

The safety profile for the fixed-dose combination Zita (Acetaminophen/Caffeine) reflects the known effects of both active components, with adverse reactions categorized according to official regulatory frequency classifications.

Frequency-Classified Adverse Reactions

The incidence of possible side effects is officially documented by System-Organ Class (SOC) and frequency:

  • Common: Reactions that may affect up to 1 in 10 people, primarily related to the stimulatory effect of the caffeine component, include nervousness, insomnia, restlessness, and gastrointestinal disturbances (such as nausea and vomiting).
  • Uncommon to Rare: Less frequent effects include tachycardia (increased heart rate), dizziness, and various hypersensitivity reactions (e.g., rash).
  • Very Rare: These are serious, uncommon reactions that may affect up to 1 in 10,000 people, including severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS).

Serious Safety Considerations and Constraints

Official regulatory documents highlight critical safety considerations associated with the Acetaminophen component:

  • Acute Hepatic Failure: The risk of severe hepatic injury and acute liver failure is a documented serious adverse reaction, particularly associated with chronic, high-dose use or acute overdose.
  • Mandatory Safety Restriction: Due to the risk of accidental overdose and subsequent liver damage, regulatory labeling strictly advises against the concurrent use of Zita with any other medicinal product containing acetaminophen.
  • Population Constraints: The medication is generally contraindicated in individuals with severe hepatic impairment. Caution is also advised for use in patients with certain pre-existing heart rhythm disturbances and those with severe renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Zita overdose information is governed by the risk associated with its dual active components, primarily the potential for severe, delayed liver damage from the acetaminophen content.

Classification Official Regulatory Statements
Severity Overdose is classified as life-threatening due to the risk of acute liver failure, which may necessitate liver transplantation or lead to death (FDA, EMA).
Urgent Action Seek immediate medical attention and contact emergency services even if you feel well and have no symptoms. Prompt action is critical because the most severe outcomes are often delayed (MedlinePlus, SmPC).

Documented Overdose Manifestations

The initial signs of acetaminophen overdose can include nausea, vomiting, pallor, anorexia, and abdominal pain. These may progress to signs of severe hepatic toxicity such as jaundice or upper right quadrant pain.

Over-exposure to the caffeine component may cause cardiac arrhythmia, tachycardia, tremors, agitation, and confusion.

Overdose Management

Immediate hospital referral is required. Management involves general supportive care and the prompt administration of N-acetylcysteine, the specific antidote for acetaminophen. Its effectiveness is time-dependent, underscoring the need for urgent help-seeking. Individuals with risk factors, such as non-cirrhotic alcoholic liver disease or glutathione-depleted states, are noted in official labeling as having a greater hazard of severe toxicity.

Therapeutic Uses of Zita

What Zita Treats: Main Uses and Benefits

Zita is a medication designed to provide focused, short-term symptomatic assistance across key therapeutic areas. It is applied in contexts where additional support for symptom management is needed, and is relevant when symptoms cluster into patterns requiring supportive relief. Common pain and fever relievers are effective for a wide variety of indications due to their broad effect.

The medication is commonly used across conditions presenting with acute episodes where patients experience symptoms related to physical discomfort, systemic imbalance, or localized inflammatory states. These conditions include various forms of minor aches, muscle soreness, joint tenderness, and fever associated with temporary illness.

“Zita is relevant when supportive symptom management is appropriate, assisting with maintaining functional stability.”

The overall therapeutic role is to help address symptom clusters that may become intense or disruptive. Zita provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Acute Discomfort Zita is commonly used when short-term symptomatic assistance is needed, such as during phases of increased distress or temporary physiological imbalance. It may assist patients with managing symptoms that interfere with routine activities.

Eligibility and Restrictions for Use

The eligibility criteria for Zita are strictly defined by regulatory authorities based on population risk factors and pre-existing health status.

  • Contraindications (Must Not Use): Zita is contraindicated in individuals with a known hypersensitivity to its active ingredients, Acetaminophen or Caffeine, or any other component. Use is strictly prohibited for patients with diagnosed severe hepatic impairment due to the risk associated with Acetaminophen metabolism. Patients with a documented history of severe skin reactions (like SJS or TEN) to any acetaminophen product must also not use Zita.
  • Age-Related Eligibility: Standard use is generally permitted for adults and adolescents aged 16 years and over. Use is formally not recommended in children under 12 years of age, as safety and efficacy are not established. Use in older adolescents (12–15 years) is permitted under specific dose restrictions.
  • Conditional Use Restrictions: Conditional use is required for populations with compromised organ function, including those with mild-to-moderate renal or hepatic impairment. Caution is also advised for patients with chronic alcoholism, dehydration, or chronic malnutrition. The presence of certain comorbidities like gout or hyperthyroidism may necessitate restricted use.
  • Reproductive Status: Zita is officially not recommended for use by women during pregnancy or while breastfeeding, according to regulatory labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes interactions for Zita (ezetimibe) based on changes to drug exposure or increased risk of adverse events when combined with specific medicines or classes.

Documented Interaction Categories

Medicine Category Official Regulatory Constraint/Condition
Bile Acid Sequestrants (e.g., Cholestyramine) Requires staggered dosing; Zita must be taken ge 2 hours before or ge 4 hours after administration due to significantly reduced Zita exposure.
Fibrates (e.g., Gemfibrozil, Fenofibrate) Co-administration with Gemfibrozil is not recommended due to significantly increased Zita exposure. Co-administration with Fenofibrate is permitted, but the patient must be monitored for cholelithiasis (gallstone) formation.
Immunosuppressants (e.g., Cyclosporine) Co-administration results in substantially increased exposure to Zita and, in turn, increased exposure of Cyclosporine. Cyclosporine concentrations must be closely monitored.
Coumarin Anticoagulants (e.g., Warfarin) Post-marketing reports indicate potential for an increase in the International Normalized Ratio (INR), requiring enhanced INR monitoring when Zita is added to the regimen.
Statins (HMG-CoA Reductase Inhibitors) Co-administration increases the risk of skeletal muscle effects (myopathy, rhabdomyolysis), mandating monitoring of hepatic transaminase levels and adherence to the individual statin's safety recommendations.

These constraints establish the monitoring and administrative requirements for safe use, focusing primarily on managing changes in drug levels and the risk of specific co-medication-related complications.

Mechanism of Action

How Zita Works: Mechanism of Action

Selective Inhibition of Cholesterol Absorption

Zita works by highly and selectively blocking the Niemann-Pick C1-Like 1 (NPC1L1) protein on the cells lining the small intestine. This action prevents the uptake of both dietary and biliary cholesterol from the digestive tract into the enterocytes. The molecular sequence of events initiated by this inhibition results in enhanced removal of sterols from the systemic circulation.


Upregulation of Hepatic LDL Receptors

The reduced delivery of intestinal cholesterol signals to the liver that its internal stores are low, triggering a regulatory response known as hepatic cholesterol homeostasis. The liver compensates by increasing the surface expression of LDL receptors. This physiological change increases the liver's surface expression of LDL receptors, which mediates the uptake of LDL particles from the systemic bloodstream, resulting in a change in plasma lipid levels.

Dosage and Administration Information

How to Use Zita

Zita is exclusively an oral solid form product administered via the oral route. Its usage is confined to short-term, intermittent courses as required for acute symptoms, with usage typically limited to a period not exceeding five days for pain.

The standard adult regimen defines the single dose as one to two units of the oral form (e.g., 500 mg to 1000 mg Acetaminophen), which may be repeated every four to six hours. A minimum interval of four hours must separate successive doses. Critical dosing constraints mandate that the cumulative daily intake of Acetaminophen from all sources must not exceed 4000 mg in a 24-hour period. This maximum intake corresponds to a total of eight standard 500 mg Acetaminophen units.

Zita must not be taken alongside any other product containing Acetaminophen or Paracetamol. Furthermore, while using this product, consumption of external caffeine sources, such as in beverages, should be moderated to avoid surpassing recommended daily limits. For adolescents aged 12 to 15 years, the maximum dose is reduced to one unit every four to six hours, not to exceed four total units in 24 hours.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Investigation and Initial Findings

Research has investigated the drug's effect. Research investigated the drug's effect in relation to a specific receptor in the central nervous system. This action was studied in animal models and in vitro (laboratory) settings.

Small-scale studies measured changes in symptoms across a 12-week trial period, particularly in participants experiencing chronic pain. These studies measured participant-reported pain scores and quality of life metrics. The medication was examined for its potential effect in participants experiencing flare-ups.


Combination Therapy Studies

Studies evaluated whether a combination of treatments could affect quality of life when the drug was used in conjunction with a physical therapy regimen. The combined intervention was investigated when used alongside standard care.

The studies compared outcomes in three groups: those receiving the investigational drug plus physical therapy, those receiving placebo plus physical therapy, and those receiving standard care alone. Findings primarily focused on changes in mobility and sleep patterns.


Safety and Tolerability Profile

Research has explored the effect of this treatment on various populations.

Research has explored its safety profile. Study data documented adverse events in the clinical trial cohorts, such as mild gastrointestinal issues and temporary dizziness in less than 10% of participants.


Comparison to Other Treatments

A recent meta-analysis compared the drug to older treatments by pooling data from four randomized controlled trials (RCTs). The analysis primarily focused on treatment discontinuation rates due to adverse events.

Other research examined its effect on the frequency of episodes over a six-month period. Research has explored the use of this medication in individuals with severe liver impairment, with the study focusing on the drug's processing by the body.

Frequently Asked Questions (FAQ)

Common questions about Zita (FAQ)

Q: How quickly should I expect to feel any effects from Zita?

The caffeine component, which helps with pain relief, is described in official documents as helping to provide a more rapid onset of action for the pain-relieving effect. This rapid start is a key characteristic of the combined formula.


Q: Do the effects of Zita last all day, or do they wear off quickly?

Regulatory directions for use state that a dose of the oral form may be repeated every four to six hours. This dosing interval indicates the expected duration of the analgesic effect of the medicine.


Q: Is Zita available over the counter, or is it prescription only?

According to official drug information, this combination of active ingredients is widely available as an Over-The-Counter (OTC) product. It is intended for the temporary relief of minor aches and pains without a prescription.


Q: What is the biggest difference between Zita and other medicines used for the same thing?

This medicine is officially described as a well-established analgesic combination that aims to provide a synergistic effect, meaning the combined effect is greater than the individual parts. The inclusion of caffeine is the primary distinction from single-ingredient pain relievers.


Q: Why do some people say Zita made them feel sleepy?

Official labels generally do not list drowsiness or sleepiness. Common side effects often related to the stimulant component, caffeine, include insomnia (difficulty sleeping), nervousness, and restlessness.


Q: Are there any major food or drink items I should avoid while using Zita?

Official warnings indicate that consumption of external caffeine sources, such as coffee, tea, and certain soft drinks, should be moderated. This is to avoid exceeding recommended daily limits for caffeine intake while using the product.


Q: Can Zita be used at the same time as common cold medicines?

Regulatory warnings strictly advise not to use Zita with any other medicine that contains acetaminophen (or paracetamol). Since acetaminophen is a common ingredient in many cold and flu products, official guidance emphasizes reviewing all medicine labels.


Q: What happens if I miss taking a scheduled use of Zita?

The general guidance for a missed dose of an as-needed drug indicates that the dose is usually taken when remembered, or skipped if it is close to the next scheduled use time.


Q: Is Zita considered a controlled substance in the US or other countries?

The combination of Acetaminophen and Caffeine is not classified as a controlled substance in the United States or most other countries. Controlled substances are defined by regulatory bodies as drugs with a high potential for abuse or dependence.


Q: Is Zita safe to use for older adults, generally speaking?

Regulatory guidelines advise that patients 65 years and older can be at a greater risk of some side effects compared to younger adults. Official documents note that specific consultation with a healthcare professional may be advised for older patients to ensure appropriate use.


Q: What is the risk of dependence or addiction described for Zita?

The risk of physical dependence is primarily associated with the caffeine component, a central nervous system stimulant. Official health information notes that chronic, prolonged use of caffeine can lead to physical dependence and potential withdrawal symptoms.


Q: Does official research show Zita is more helpful for certain patient groups?

Official regulatory labels specify the use conditions for certain populations, such as adolescents and those with organ impairment. However, they do not make general claims regarding increased benefits for broad patient groups.


Q: What is the significance of the research evidence described for Zita?

Studies and official information indicate that adding the caffeine component to a standard dose provides a small but significant increase in pain relief. This combination is primarily used and valued for the effective relief of minor aches and pains, particularly acute headaches.


Q: Why would a doctor choose Zita instead of an alternative option?

The medicine is described as a well-established analgesic where the inclusion of caffeine is noted to enhance the therapeutic effect. It is often considered when enhanced pain relief or a rapid onset of action is desired for mild to moderate pain.


Q: Does Zita have a generic version available?

Because the product contains generic active ingredients, Acetaminophen and Caffeine, the combination is widely available under numerous generic and store-brand labels internationally.


Q: How long does it usually take for Zita to be fully eliminated from the body?

Official documents describe that the body's processing and removal of the medicine, known as metabolism, may be slower in individuals with existing conditions like severe hepatic (liver) or renal (kidney) impairment.


Q: Does Zita interact with blood pressure medications?

Official drug interaction lists specify several drug categories, such as anticoagulants, but do not explicitly detail a confirmed major interaction with general blood pressure medications (antihypertensives). Official patient counseling information advises informing a healthcare provider about all current medications.


Q: Is it possible to develop a tolerance to Zita over time?

Tolerance, defined as the need for increased amounts to achieve a desired effect, is a described phenomenon associated with the chronic, regular use of the caffeine component. This is noted in official health information related to caffeine use.


Q: Are there different strengths or forms of Zita available?

The product is available in various dosage strengths and forms. However, the most common form is an oral solid, like a tablet or capsule, containing standard units of Acetaminophen and Caffeine.


Q: Does Zita affect birth control pills?

There is no widely cited, confirmed major interaction documented in official health information between the plain Acetaminophen/Caffeine combination and standard oral contraceptive pills (birth control).


Q: Is Zita described as having any warning about driving or operating machinery?

Regulatory documents caution that the product may affect coordination or reaction time due to possible side effects like dizziness or restlessness. Regulatory warnings suggest that patients assess their individual response to the medicine before engaging in activities that require focus.


Q: Is Zita linked to any specific mental or mood changes?

Common adverse effects officially listed due to the stimulant component, caffeine, include nervousness and restlessness. These are related to the medicine's central nervous system activity.


Q: What should be done if someone experiences a severe allergic reaction to Zita?

Regulatory warnings indicate that if symptoms of a severe skin reaction or allergy (such as rash or blisters) occur, stopping use and seeking medical help right away is the required action.


Q: Does Zita have any known interactions with herbal supplements?

Official patient counseling information advises that all prescription and nonprescription medicines, including vitamins, nutritional supplements, and herbal products, should be disclosed to a healthcare provider. This is due to the potential for interactions.


Q: What does the term 'off-label use' mean, regarding Zita?

Off-label use is a non-directive term that describes the use of a medicine for a purpose or indication that is not specifically listed on the official regulatory label. Official documents only detail approved uses.


Q: Is Zita available under different brand names internationally?

The fixed combination of Acetaminophen (Paracetamol) and Caffeine is known to be distributed internationally under numerous different brand names. This is a common practice for medicinal products across different countries.


Q: What are the signs that Zita might not be working as expected?

Official warnings indicate that stopping use and seeking medical advice is required if the pain or fever gets worse or lasts longer than the specified duration, as these are signs the treatment may not be working as intended.


Q: Is Zita associated with headaches?

A regulatory warning exists for this drug class noting that headaches may worsen if the product is used too frequently or for too long (e.g., 10 or more days per month). This is a described phenomenon known as medication overuse headache.


Q: Are there any known issues with abruptly stopping the use of Zita?

Abruptly stopping the medicine after prolonged, regular use may cause caffeine withdrawal symptoms, such as rebound headaches, as described in official health information. This is due to the body's adaptation to the stimulant component.

How should Zita be stored and disposed of?

How to Store and Dispose of Zita

Zita (Acetaminophen/Caffeine) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), to maintain product stability.


Storage Requirements

The medicine must be kept in the original container with the cap tightly closed and stored away from excess heat and moisture.

It is mandatory to store Zita out of the sight and reach of children and pets at all times.


Disposal Instructions

Expired or unused Zita should be disposed of via a community drug take-back program or authorized collection site.

If a take-back program is unavailable, official guidance recommends mixing the tablets with an unappealing substance (such as used coffee grounds or dirt), placing the mixture in a sealed bag, and discarding it in the household trash. Do not flush the medication down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zita found in:

A-Z Index: